参考文献/References:
[1] Blau M, Nagler W, Bender MA. Fluorine-18:a new isotope for bone seanning. J Nuel Med, 1962, 3:332-334.
[2] Grant FD, Fahey FH, Packard AB, et al. Skeletal PET with 18F-fluoride:applying new technology to an old tracer. J Nucl Med, 2008, 49(1):68-78.
[3] Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, lSF-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med, 2006, 36(1):73-92.
[4] Even-Sapir E, Mishani E, Flusser G, et al. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med, 2007, 37(6):462-469.
[5] Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease:initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med, 2004, 45(2):272-278.
[6] Krasnow AZ, Hellman RS, Timins ME, et al. Diagnostic bone scanning in oncology. Semin Nucl Med, 1997, 27(2):107-141.
[7] Rubens RD. Bone metastases-incidence and complications//Rubens RD, Mundy GR. Cancer and the skeleton. London:Martin Dunitz, 2000:33-42.
[8] Coleman RE. The role of bone markers in metastatic bone disease. Cancer Treat Rev, 2006, 32(Suppl 1):1-2.
[9] Blake GM, Park-Holohan SJ, Cook GJ, et al. Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonata Semin Nucl Med, 2001, 31(1):28-49.
[10] Fogelman I, Cook G, Israel O, et al. Positron emission tomography and bone metastases. Semin Nucl Med, 2005, 35(2):135-142.
[11] 李彦生,王俊起,刘磊,等.18F-NaF的合成及其在肺癌骨转移中的临床应用.中华核医学杂志,2006,26(1):18-20.
[12] Even-Sapir E, Metser U, Mishani E, et al. The detection of bone metastases in patients with high-risk prostate cancer:99mTc-MDP planar bone scintigraphy, single-and multi-field-of-view SPECT, 18F-fluoride PET, and tSF-fluoride PET/CT. J Nucl Med, 2006, 47(2):287-297.
[13] Nakamoto Y, Cohade C, Tatsumi M, et al. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology, 2005, 237(2):627-634.
相似文献/References:
[1]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[2]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[3]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[4]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[5]张艳兰,孙琦婷,武萍,等.呼吸门控PET/CT对于肺癌放疗靶区勾画的指导[J].国际放射医学核医学杂志,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
Zhang Yanlan,Sun Qiting,Wu Ping,et al.Guiding the target delineation in radiation therapy of lung cancer by respiratory gated PET/CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
[6]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[7]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[8]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[9]张高潮,马丽,寇莹,等.99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值[J].国际放射医学核医学杂志,2015,39(4):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
Zhang Gaochao,Ma Li,Kou Ying,et al.Clinical value of 99Tcm-tetrofosmin SPECT in the diagnosis of lung neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
[10]付畅,史大鹏,徐俊玲,等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
Fu Chang,Shi Dapeng,Xu Junling,et al.The preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
[11]佟丽娟,王明泽,王丽梅.肺癌、乳腺癌、食道癌远端骨转移特点的对比研究[J].国际放射医学核医学杂志,2011,35(1):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
TONG Li-juan,WANG Ming-ze,WANG Li-mei.Comparative study between characteristics of the lung cancer, breast cancer and esophageal cancer distal bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):38.[doi:10.3760/cma.j.issn.1673-4114.2011.01.011]
[12]刘长江,董燕玉.99Tcm-depreotide显像对肺部病灶的鉴别诊断价值[J].国际放射医学核医学杂志,2009,33(2):79.[doi:10.3760/cma.j.issn.1673-4114.2009.02.005]
LIU Chang-fiang,DONG Yan-yu.The clinical value of 99Tcm-depreotide scintigraphy in differentiating malignant from benign lesions in the lung[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):79.[doi:10.3760/cma.j.issn.1673-4114.2009.02.005]
[13]杜晓光,闫志华,孟玉葆.562例原发肺癌患者核素骨显像结果分析[J].国际放射医学核医学杂志,2009,33(6):346.[doi:10.3760/cma.j.issn.1673-4114.2009.06.008]
DU Xiao-guang,YAN Zhi-hua,MENG Yu-bao.Analysis of bone imaging results of 562 primary lung carcinoma patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):346.[doi:10.3760/cma.j.issn.1673-4114.2009.06.008]